✦ LIBER ✦

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial

✍ Scribed by Shahar Lavi; Warren J. Cantor; Amparo Casanova; Mary K. Tan; Andrew T. Yan; Vladimír Džavík; David Fitchett; Eric A. Cohen; Bjug Borgundvaag; Michael Heffernan; John Ducas; Shaun G. Goodman

Book ID: 116192651
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 229 KB
Volume: 163
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2011.10.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of tenecteplase in c

Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 116 KB

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin vs. intravenous unfractionated heparin and tirofiban vs. placebo in the treatment of acute st-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

✍ M Cohen; G.F Gensini; F Maritzet al 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effect of enoxaparin versus unfractionat

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction study 25 (ExTRACT–TIMI 25) trial

✍ David A. Morrow; Elliott M. Antman; Sabina A. Murphy; Jie Qin; Mikhail Ruda; Sem 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Baseline NT-proBNP and biomarkers of inf

Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

✍ Sean van Diepen, Matthew T. Roe, Renato D. Lopes, Amanda Stebbins, Stefan James, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 235 KB

Efficacy and safety of enoxaparin compar

Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial

✍ Harvey D. White; Neal S. Kleiman; Kenneth W. Mahaffey; Yuliya Lokhnygina; Karen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Adjunctive benefits from low-molecular-w

Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials

✍ Giuseppe De Luca; Paolo Marino 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 433 KB